Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios
Epilepsy represents a challenge in the management of patients with brain tumors. Epileptic seizures are one of the most frequent comorbidities in neuro-oncology and may be the debut symptom of a brain tumor or a complication during its evolution. Epileptogenic mechanisms of brain tumors are not yet...
Main Authors: | José Manuel Sánchez-Villalobos, Ángel Aledo-Serrano, Irene Villegas-Martínez, Mohd Farooq Shaikh, Miguel Alcaraz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.991244/full |
Similar Items
-
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01) -
Comparative analysis of three decades' experience in the management of pregnant women with epilepsy: a real-life scenario
by: Réka Válóczy, et al.
Published: (2023-09-01) -
Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
by: Shino Yoshida, et al.
Published: (2023-07-01) -
Perampanel’s forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy
by: Michelle Guignet, et al.
Published: (2023-09-01) -
Managing reproductive problems in women with epilepsy of childbearing age
by: Wanlin Lai, et al.
Published: (2021-11-01)